These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28188750)

  • 1. KRAS and PIK3CA mutations in colorectal adenocarcinomas correlate with aggressive histological features and behavior.
    Jang S; Hong M; Shin MK; Kim BC; Shin HS; Yu E; Hong SM; Kim J; Chun SM; Kim TI; Choi KC; Ko YW; Kim JW
    Hum Pathol; 2017 Jul; 65():21-30. PubMed ID: 28188750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer.
    Kawazoe A; Shitara K; Fukuoka S; Kuboki Y; Bando H; Okamoto W; Kojima T; Fuse N; Yamanaka T; Doi T; Ohtsu A; Yoshino T
    BMC Cancer; 2015 Apr; 15():258. PubMed ID: 25886136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer.
    Guedes JG; Veiga I; Rocha P; Pinto P; Pinto C; Pinheiro M; Peixoto A; Fragoso M; Raimundo A; Ferreira P; Machado M; Sousa N; Lopes P; Araújo A; Macedo J; Alves F; Coutinho C; Henrique R; Santos LL; Teixeira MR
    BMC Cancer; 2013 Apr; 13():169. PubMed ID: 23548132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset.
    Berg M; Danielsen SA; Ahlquist T; Merok MA; Ågesen TH; Vatn MH; Mala T; Sjo OH; Bakka A; Moberg I; Fetveit T; Mathisen Ø; Husby A; Sandvik O; Nesbakken A; Thiis-Evensen E; Lothe RA
    PLoS One; 2010 Nov; 5(11):e13978. PubMed ID: 21103049
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    El Zaitouni S; Laraqui A; Ghaouti M; Benzekri A; Kettani F; Bajjou T; Sekhsokh Y; Benmokhtar S; Jafari M; Baba W; Oukabli M; El Annaz H; Abi R; Tagajdid MR; El Kochri S; Lahlou IA; Ameziane El Hassani R; Ennibi K
    Cancer Control; 2024; 31():10732748241262179. PubMed ID: 38875469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation Profile via Next-Generation Sequencing in Patients with Colorectal Adenocarcinoma and Its Clinicopathological Correlation.
    Osman S; Kahraman Çetin N; Erdoğdu İH; Meteoğlu İ
    Turk J Gastroenterol; 2023 Nov; 34(11):1124-1133. PubMed ID: 37737217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical-Molecular characteristics and Post-Translational modifications of colorectal cancer in north China: Implications for future targeted therapies.
    Chi Y; Yuan H; Fan Q; Wang Z; Niu Z; Yu J; Yuan D
    Gene; 2024 Mar; 899():148134. PubMed ID: 38185290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma ctDNA enhances the tissue-based detection of oncodriver mutations in colorectal cancer.
    Wang W; Huang Y; Kong J; Lu L; Liao Q; Zhu J; Wang T; Yan L; Dai M; Chen Z; You J
    Clin Transl Oncol; 2024 Aug; 26(8):1976-1987. PubMed ID: 38777950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia.
    Palomba G; Colombino M; Contu A; Massidda B; Baldino G; Pazzola A; Ionta M; Capelli F; Trova V; Sedda T; Sanna G; Tanda F; Budroni M; ; Palmieri G; Cossu A; Contu M; Cuccu A; Farris A; Macciò A; Mameli G; Olmeo N; Ortu S; Petretto E; Pusceddu V; Virdis L
    J Transl Med; 2012 Aug; 10():178. PubMed ID: 22931052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of KRAS, NRAS, BRAF and PIK3CA gene mutations with clinicopathological features, prognosis and ring finger protein 215 expression in patients with colorectal cancer.
    Wu JB; Li XJ; Liu H; Liu YJ; Liu XP
    Biomed Rep; 2023 Dec; 19(6):104. PubMed ID: 38025833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMAD4--molecular gladiator of the TGF-beta signaling is trampled upon by mutational insufficiency in colorectal carcinoma of Kashmiri population: an analysis with relation to KRAS proto-oncogene.
    Sameer AS; Chowdri NA; Syeed N; Banday MZ; Shah ZA; Siddiqi MA
    BMC Cancer; 2010 Jun; 10():300. PubMed ID: 20565773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation profiling of cancer drivers in Brazilian colorectal cancer.
    Dos Santos W; Sobanski T; de Carvalho AC; Evangelista AF; Matsushita M; Berardinelli GN; de Oliveira MA; Reis RM; Guimarães DP
    Sci Rep; 2019 Sep; 9(1):13687. PubMed ID: 31548566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Driver and targetable alterations in Chinese patients with small bowel carcinoma.
    Li J; Li X; Dong N; Yan S; Jing C; Ma T; Li W; Zhang C; Cai Y; Deng W
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6139-6150. PubMed ID: 36680582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer.
    Kwak Y; Koh J; Kim DW; Kang SB; Kim WH; Lee HS
    Oncotarget; 2016 Dec; 7(49):81778-81790. PubMed ID: 27835889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation Analysis of KRAS and BRAF in Iranian Colorectal Cancer patients: A Novel Variant in Exon 15 of BRAF.
    Hassani B; Alizadeh R; Akouchekian M; Safarnezhad Tameshkel F; Karbalaie Niya MH
    Asian Pac J Cancer Prev; 2023 Nov; 24(11):3665-3671. PubMed ID: 38019223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of KRAS Mutation in Patients With Sporadic Nonampullary Duodenal Epithelial Tumors.
    Kinugasa H; Kanzaki H; Tanaka T; Yamamoto S; Yamasaki Y; Nouso K; Ichimura K; Nakagawa M; Mitsuhashi T; Okada H
    Clin Transl Gastroenterol; 2021 Nov; 12(11):e00424. PubMed ID: 34797780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating cfDNA liquid biopsy and organoid-based drug screening reveals PI3K signaling as a promising therapeutic target in colorectal cancer.
    Yang H; Xiao X; Zeng L; Zeng H; Zheng Y; Wang J; Li G; Dai W; He Y; Wang S; Peng J; Chen W
    J Transl Med; 2024 Feb; 22(1):132. PubMed ID: 38310289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted panel sequencing of pharmacogenes and oncodrivers in colorectal cancer patients reveals genes with prognostic significance.
    Heczko L; Liška V; Vyčítal O; Fiala O; Šůsová S; Hlaváč V; Souček P
    Hum Genomics; 2024 Jul; 18(1):83. PubMed ID: 39030589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clear Cell Squamous Cell Carcinoma of the Maxillary Gingiva Associated with PIK3CA and HRAS Mutations: Report of a Case and Literature Review.
    Hirose K; Shibahara T; Teramoto A; Usami Y; Ono S; Iwamoto Y; Murakami S; Oya K; Uzawa N; Motooka D; Hori Y; Morii E; Toyosawa S
    Head Neck Pathol; 2023 Dec; 17(4):1026-1033. PubMed ID: 37735286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experience.
    Gong J; Cho M; Sy M; Salgia R; Fakih M
    Oncotarget; 2017 Jun; 8(26):42198-42213. PubMed ID: 28178681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.